Company / Net Income
Enovis Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$1.2B
FY2025
5-year range
-$1.2B / $71.7M
FY2021-FY2025
Trend
-43.5%
vs FY2024
Sector context
#163 of 164
Health Care
What the data says
Among 164 Health Care companies, Enovis is in the bottom 1% for net income. Net Income has fluctuated over the past 10 years, ranging from -$1.2B in FY2025 to $168M in FY2017.
Based on SEC 10-K filings.
-$1.2B in FY2025.
Declined from $72M to -$1.2B over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 1% in Health CareTop 99% of 164This company -$1.2B Sector average $467.5M
▼
-353.3% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 43.5% year-over-year.
- Ranks #163 out of 164 companies in the Health Care sector.
- Peak net income was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.2B | -43.5% |
| FY2024 | -$825.5M | -1252.0% |
| FY2023 | $71.7M | +68.1% |
| FY2022 | $42.6M | -40.5% |
| FY2021 | $71.7M | -48.9% |
| FY2020 | $140.2M | -7.2% |
| FY2019 | $151.1M | +7.8% |
| FY2018 | $140.2M | -16.4% |
| FY2017 | $167.7M | +30.9% |
| FY2016 | $128.1M | -28.3% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026